Work

0729 Improvements in Quality of Life in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton

Year: 2026

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0728

Authors: Gert Jan Lammers, Yves Dauvilliers, Ron Grunstein, Emmanuel Mignot, David Plante, Erik Buntinx, Rafael Del Rio Villegas, Hailu Chen, Craig Hopkinson, Bhaskar Rege, Julie Himes, Michael Doane, Giuseppe Plazzi

Institutions: Leiden University Medical Center, Inserm, Université de Montpellier, Hôpital Gui de Chauliac, Institute for Neurosciences of Montpellier, Woolcock Institute of Medical Research, Macquarie University, Stanford Medicine, Stanford University, University of Wisconsin–Madison, Alkermes (United States), Istituto delle Scienze Neurologiche di Bologna

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160654910

Cites:

Cited by:

Related to: